Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Callaghan Innovation Co-Funding Enables Large Herd Trials

Press release
March 25, 2013

Callaghan Innovation Co-Funding Enables Large Herd Trials For Kahne

Kahne Animal Health (Kahne) today announced that Callaghan Innovation will co-fund a large-herd testing project for their world-first sensor-based wireless monitoring systems used to track health and fertility in cows.

Callaghan Innovation will provide $1 million towards testing the biotelemetry-based rumen and fertility monitoring devices which measure temperature, pH levels and identify oestrus indicators in cows. The devices track and transmit data to provide farmers with health alerts and reports to help with the early detection of health problems, effectiveness of nutrition management, disorders that could impact fertility, and accurate oestrus detection.

Kahne Chief Executive, Susanne Clay, said while there is a global market for the technology, the company has given priority to the local market to help Kiwi farmers solve livestock issues to drive efficiencies that impact their bottom lines.

“Kahne has two products under development – SentinelTM, a rumen monitoring system, and CatalystTM, a fertility monitoring system – both of which will deliver never-before available support to farmers and their advisors, helping improve the productivity, health and sustainability of ruminant livestock.

“500 prototype units have been sold to researchers around the world, but with the co-funding received from Callaghan Innovation we are now able to complete development and validate the system at scale with commercial herds,” she said.

Acting General Manager of Business R&D Grants at Callaghan Innovation, Graham Smith, is pleased Callaghan Innovation is able to provide grants to support companies like Kahne that are involved in research and development.

“At Callaghan Innovation we aim to accelerate commercialisation of innovation in New Zealand firms, grants like these are just one of the ways we enable businesses to invest more in research, science, engineering and technology so they can be more successful,” said Mr Smith.

The grant from Callaghan Innovation follows a successful funding round late last year led by Wellington based venture fund Movac.

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Reserve Bank: RBNZ To Implement $30bn Large Scale Asset Purchase Programme Of NZ Govt Bonds

The Monetary Policy Committee (MPC) has decided to implement a Large Scale Asset Purchase programme (LSAP) of New Zealand government bonds. The negative economic implications of the coronavirus outbreak have continued to intensify. The Committee ... More>>

ALSO:

Elevate NZ: Venture Fund To Lift Productivity

The Government’s new $300 million venture capital fund - announced in last year’s Budget – is now open for business as the Elevate NZ Venture Fund. Finance Minister Grant Robertson says lifting New Zealand's productivity requires well-functioning ... More>>

ALSO:


COVID-19: Case Confirmed In NZ – Expert Reaction

After spreading across the globe for months, the first case of COVID-19 has been reported in New Zealand. The Ministry of Health says the risk of a community outbreak is low, due to their preparedness and the high awareness of the disease. The Science ... More>>

ALSO:

Agriculture: New Legislation To Boost Organics

New organics legislation will boost consumer confidence and help grow an innovative sector, says Food Safety Minister Damien O’Connor. “The Organics Product Bill, introduced to Parliament this week, aims to increase consumer confidence when purchasing ... More>>

ALSO:

Biodiversity Policy: Misinformation Circulating

Forest & Bird is concerned at misinformation circulating regarding a policy statement aimed at protecting New Zealand’s unique biodiversity. The National Policy Statement for Indigenous Biodiversity is being consulted on by the ... More>>

ALSO: